Novartis AG

Type: Company
Name: Novartis AG
Nationality: Switzerland
Web Address: http://www.novartis.com
Fact Sheet: Fact Sheet for Novartis India Ltd
First reported 1 hour ago - Updated 1 hour ago - 1 reports

Illness-Treating Contact Lenses

Google and pharmaceutical giants Novartis are teaming up to develop Google Lens, a smart contact lens that could have a wide array of medical applications. The technology-packed lenses could help people suffering from visibility problems and other il ... [Published Trend Hunter - 1 hour ago]
First reported 1 hour ago - Updated 1 hour ago - 1 reports

Key Account Managers, New Dermatology Team, Scotland and Wales

Key Account Managers.Territories - UK Wide, Scotland, Wales, England - South West, South East, East Midlands, West Midlands, North East, North West, East Anglia, London.Novartis are building a new team which offers exciting opportunities for exceptional ... [Published Pharma Field - 1 hour ago]
Entities: Dermatology, Wales, Scotland
First reported 4 hours ago - Updated 4 hours ago - 1 reports

Google wearables to add to planned bioinformatics database

Google and Novartis are teaming up to develop Google's "smart lens" technology for glucose monitoring and presbyopia.--Courtesy of GoogleGoogle ($GOOG) isn't just searching the Internet. The company will soon search the insides of people's bodies for ... [Published FierceMedicalDevices - 4 hours ago]
First reported 21 hours ago - Updated 5 hours ago - 6 reports

Novartis Division Gets European Approval for Simbrinza

Novartis’ ( NVS ) ophthalmology division, Alcon, received encouraging news when Simbrinza was approved by the European Commission.Simbrinza has been approved in Europe to decrease elevated intraocular pressure (:IOP) in adult patients with open-angle ... [Published Yahoo! Finance - 5 hours ago]
First reported 11 hours ago - Updated 7 hours ago - 2 reports

Drug Companies Oppose Moves to Reimburse Off-Label Medicine

Drugmakers have expressed opposition to moves by European governments to provide reimbursement for off-label drug use, The Wall Street Journal reported. Last month, Italy became the first country to permit its health system to provide reimbursement for ... [Published FirstWord Pharma - 7 hours ago]
First reported Jul 27 2014 - Updated 9 hours ago - 12 reports

GSK open to selling healthcare business

Britain's GlaxoSmithKline is considering spinning off its consumer division in future, according to a report in the Financial Times, as part of a restructuring of the drugmaker. As Joanna Partridge reports, it comes after a damaging China bribery scandal, ... [Published Reuters India - 10 hours ago]
First reported 10 hours ago - Updated 10 hours ago - 1 reports

Court Report - July 2014 #3

About Court Report:  Each week we will report briefly on recently filed biotech and pharma cases .GlaxoSmithKline LLC et al. v. Glenmark Generics Inc. USA1:14-cv-00877; filed July 3, 2014 in the District Court of Delaware• Plaintiffs:  GlaxoSmithKline ... [Published JD Supra - 10 hours ago]
First reported 14 hours ago - Updated 12 hours ago - 2 reports

Novartis AG Given Consensus Rating of “Hold” by Brokerages (NYSE:NVS)

Novartis AG (NYSE:NVS) has earned an average rating of "Hold" from the eight ratings firms that are covering the company, AnalystRatingsNetwork reports. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation ... [Published American Banking News - 12 hours ago]
First reported 12 hours ago - Updated 12 hours ago - 1 reports

Morris Habitat makes headway on new duplex with help from Novartis volunteers

Novartis volunteers are tired but satisfied with all the work done for Morris Habitat at the build site. Front row (from left): Karen Steinmetz, Maria Lopes, Gregory Amiro, Deborah Struller, Lindsey Newman, Releford, Chona Cairme, Kara Simpson, Asher ... [Published Independent Press - 12 hours ago]
First reported 13 hours ago - Updated 13 hours ago - 1 reports

Google Smart Lenses May Treat and Detect Illness

Novartis and Google have partnered to develop a contact lens with the potential for a wide array of medical and lifestyle uses. Packed with technology, the lenses are designed to assist sufferers of serious illness and nearsightedness alike.Novartis’ ... [Published PSFK - 13 hours ago]
First reported 15 hours ago - Updated 15 hours ago - 1 reports

Omalizumab Effective for Chronic Hives up to 24 Weeks

Omalizumab ( Xolair , Genentech Inc and Novartis Pharmaceuticals Corporation) is effective at controlling chronic hives for up to 24 weeks, according to results of a clinical trial by Sarbjit S. Saini, MD, from the Johns Hopkins Asthma and Allergy Center, ... [Published American Journal of Public Health - 15 hours ago]
First reported 17 hours ago - Updated 17 hours ago - 1 reports

Novartis announces NEJM publication of two pivotal Phase III secukinumab studies

Novartis today announced that The New England Journal of Medicine (NEJM) published the results from two pivotal Phase III studies evaluating the interleukin-17A (IL-17A) inhibitor secukinumab (AIN457). Secukinumab met all primary and key secondary endpoints ... [Published Drugs.com - 17 hours ago]

Quotes

...about healthcare regulations, saying during this month's Khosla Ventures CEO Summit that the industry is "just a painful business to be in" because "the regulatory burden in the U S is so high that I think it would dissuade a lot of entrepreneurs."
A common prescription for a big data headache is technology. "With volume, you can use Hadoop; with velocity, you can use Storm" Mark Schreiber , associate director of knowledge engineering at Novartis International AG , said
...FDA does have the power to grant more leeway in these trials than it would for a novel drug, as it stated in a 2012 draft guidance on the BCPIA: "The scope and magnitude of clinical studies will depend on the extent of residual uncertainty about the biosimilarity of the two products after conducting structural and functional characterization and possible animal studies."
"We've seen Astra Zeneca come into the eyes of Pfizer, as part of a tax inversion deal, obviously that's been rebuffed, we've got AbbVie and Shire, we've also seen a number of other deals come to the fore, the Allergan deal as well, so the pharmaceutical sector I think at the moment is ripe for consolidation."

More Content

All (3298) | News (2547) | Reports (0) | Blogs (674) | Audio/Video (6) | Fact Sheets (32) | Press Releases (32)
sort by: Date | Relevance
Fitness Diary: Running and Triathlon fixtures t... [Published Irish Independent - 19 mins ago]
Illness-Treating Contact Lenses [Published Trend Hunter - 1 hour ago]
Key Account Managers, New Dermatology Team, Sco... [Published Pharma Field - 1 hour ago]
Google wearables to add to planned bioinformati... [Published FierceMedicalDevices - 4 hours ago]
Novartis Division Gets European Approval for Si... [Published Yahoo! Finance - 5 hours ago]
AAP updates recommendations on meningococcal va... [Published Orthopedics Today - 5 hours ago]
Drug Companies Oppose Moves to Reimburse Off-La... [Published FirstWord Pharma - 7 hours ago]
Man plus machine required for big data variety [Published SearchCIO.com - 7 hours ago]
Testing an Accelerated Path for Biosimilars [Published Bio-IT World - 7 hours ago]
Sandoz takes step toward first U.S. generic bio... [Published Drug Store News - 8 hours ago]
MorphoSys' (MPSYF) CEO Simon Moroney on Q2 2014... [Published Seeking Alpha - 9 hours ago]
Ben Venue assets will bolster sterile injectabl... [Published In-Pharmatechnologist - 9 hours ago]
GSK open to selling healthcare business [Published Reuters India - 10 hours ago]
VEA, AZIA: Big ETF Inflows [Published Individual.com - 10 hours ago]
Reckitt Benckiser to spin out pharma; GSK views... [Published Pharma Letter - 10 hours ago]
Will GlaxoSmithKline plc Split Itself In Two? [Published Yahoo! UK and Ireland - 10 hours ago]
Smartglasses vs smart lenses: what is Google Sm... [Published PC Advisor - 10 hours ago]
Why Pfizer Will Trade At $40 On Improved Drug P... [Published BioPortfolio - 10 hours ago]
Will GlaxoSmithKline plc Split Itself In Two? [Published Interactive Investor - 10 hours ago]
Court Report - July 2014 #3 [Published JD Supra - 10 hours ago]
Bang! And the drugs are gone! [Published Telegraph - 10 hours ago]
The quest for global e-talent [Published TechNet Blogs - 11 hours ago]
Google’s mixed messaging about its healthcare p... [Published Mobihealthnews - 11 hours ago]
Top 10 animal health companies of 2013 [Published Fierce CRO - 11 hours ago]
Glaxo denies report of consumer health care spi... [Published Lincoln Journal Star - 11 hours ago]
Deutsche Boerse : European Stocks Slump Despite... [Published 4 Traders - 11 hours ago]
Pharma is a good play right now - Hewson [Published 4 Traders - 11 hours ago]
Roche, Novartis protest moves in EU to pay for ... [Published FiercePharma - 11 hours ago]
Why Pfizer Will Trade At $40 On Improved Drug P... [Published Seeking Alpha - 11 hours ago]
Upcoming AdComms By Subject Matter [Published Eye on FDA - 11 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
The quest for global e-talent [Published TechNet Blogs - 11 hours ago]
While in Geneva at the ITU World Summit on the Information Society (WSIS), I talked with Namir Anani, President and CEO of the Information and Communications Technology Council ( ICTC ) and invited him to provide his views since they impact ICT executives ...
Upcoming AdComms By Subject Matter [Published Eye on FDA - 11 hours ago]
In February and in April I posted a listing of upcoming advisory committees by subject matter and people seemed to like this way of looking at it, so I try to repeat it every so often.  Today is every so often.  It is just a different way of ...
Novartis AG (NVS) Trading Near $89.02 Resistanc... [Published MarketIntelligenceCenter.com - 15 hours ago]
Novartis AG (NVS) closed Friday at $88.41 and technical indicators recently have been bearish. Based in part on those numbers, MarketIntelligenceCenter.com's patented algorithms have identified a couple of attractive trading opportunities in Novartis ...
Biosimilars/Follow-on-Biologics Market is Expec... [Published PR.com Press Releases - Jul 25 2014]
Portland, OR, July 25, 2014 --( PR.com )-- A new report by Allied Market Research titled, "Global biosimilars/follow-on-biologics market (types, applications and geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, ...
Novartis AG (NVS) Showing Bearish Technicals [Published MarketIntelligenceCenter.com - Jul 25 2014]
After Thursday’s trading in Novartis AG (NVS) MarketIntelligenceCenter.com's option trade-picking algorithms uncovered a trade that offers a 3.15% or 6.53% (for comparison purposes only), while providing 4.82% downside protection. The trade is a Jan. ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Lackluster Day On Wall Street Equals A Mixed Close [Published Wall Street Journal What's News - Jul 15 2014]
TECH PM -- Google and Novartis Team Up [Published Wall Street Journal Tech News Briefing - Jul 15 2014]
Big pharma braces for M&A wave [Published Reuters Video: Business - Apr 22 2014]
Novartis And GlaxoSmithKline Doing Deals [Published Wall Street Journal What's News - Apr 22 2014]
Novartis CEO: Revamp leaves us "fighting fit" [Published Reuters Video: Top News - Apr 22 2014]
1 2

Press Releases

sort by: Date | Relevance
Global Nicotine Gum Market 2014-2018: Key Vendo... [Published GlobeNewswire: Acquisitions News - Jul 24 2014]
Technical Coverage on Pharma Stocks -- GlaxoSmi... [Published Financial Services - Jul 22 2014]
Hopp Acquires LTS Shares From Novartis & BWK [Published Financial Services - Jul 17 2014]
New Board Director, Clinical Trial Results, New... [Published Financial Services - Jul 10 2014]
Kosher Certifications, Biologic License Applica... [Published Financial Services - Jul 07 2014]
1 2 3 4 5 6 7
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.